ARS Pharmaceuticals, Inc.SPRYNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
106.79%
↓ 41% below average
Average (22q)
179.56%
Historical baseline
Range
High:4086.70%
Low:-100.00%
Volatility
2331.6%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 106.79% |
| Q2 2025 | 97.13% |
| Q1 2025 | -90.79% |
| Q4 2024 | 4086.70% |
| Q3 2024 | 313.60% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | -50.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | -100.00% |
| Q3 2022 | -59.27% |
| Q2 2022 | -30.02% |
| Q1 2022 | -12.07% |
| Q4 2021 | 42.80% |
| Q3 2021 | -75.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |